Is FMS a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

409 people get FMS articles and Market Currents by email alert.

Get email alerts on FMS »

HEADLINES:

Fresenius Medical Care Fights Short-Term Headwinds
ITT Investment Research • Thu, May 9 • 1 Comment
Fresenius Medical Care AG & Co. KGAA Management Discusses Q1 2013 Results - Earnings Call Transcript
Tue, Apr 30
German Blue-Chips Are Increasing Dividend Payouts
David Hunkar • Mon, Apr 29 • 11 Comments
Here Are The Reasons To Own Keryx And Why Catalysts Are De-Risked
PropThink • Fri, Apr 12 • 1 Comment
Rockwell Poised For Post-Offering Bounce Ahead Of Phase III Results
Mike Havrilla • Fri, Mar 22 • 4 Comments
A Unique First-To-Market Investment Opportunity Look Into Sepsis, The 10th Most Common Cause Of Death
Edward Abraham • Tue, Mar 12 • 1 Comment
Amgen And The Biosimilar Threat: Lessons From Affymax
PropThink • Fri, Mar 8 • 3 Comments
Fresenius Medical Care AG & Co. KGAA Management Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Feb 26
Affymax: Dialysis Provider Pauses Omontys Pilot Expansion, Dead Money For Now
PropThink • Thu, Feb 14 • 6 Comments
Should Investors Buy The Defense Sector?
Monty Spivak • Mon, Jan 28 • 5 Comments
Affymax: Investor Darling In 2012 Now Has To Perform In 2013
Steve Daly • Mon, Jan 21 • 3 Comments
Comparing Dividend Payout Ratios Across Regions
David Hunkar • Wed, Dec 26, 2012 • 1 Comment
Affymax Poised To Snap Back
PropThink • Thu, Dec 20, 2012 • 5 Comments
Keryx Is Completely Misunderstood And May Double On Data
PropThink • Wed, Nov 21, 2012 • 1 Comment
World Demographics: Embracing The Gracious Aging World
Nick Chiu • Fri, Nov 16, 2012 • 15 Comments
Buy Rider Systems For Cheap Valuations, Dividends And Cost Cutting Measures
Qineqt • Wed, Oct 31, 2012
Fresenius Medical Care AG & Co. KGAA Management Discusses Q3 2012 Results - Earnings Call Transcript
Wed, Oct 31, 2012
Berkshire Hathaway, Hedge Funds Are Buying DaVita
Qineqt • Tue, Oct 30, 2012 • 2 Comments
Ryder Systems: The Dividend Stock Is Cheap And Will Benefit From The Shale Gas Boom
Qineqt • Tue, Oct 9, 2012 • 2 Comments
Time To Follow Berkshire Into DaVita?
Tim Travis • Tue, Oct 2, 2012 • 10 Comments

To learn more about Seeking Alpha Pro, click here.

Fresenius Medical Care Fights Short-Term Headwinds
ITT Investment Research • Thu, May 9 • 1 Comment

German Blue-Chips Are Increasing Dividend Payouts
David Hunkar • Mon, Apr 29 • 11 Comments
Here Are The Reasons To Own Keryx And Why Catalysts Are De-Risked
PropThink • Fri, Apr 12 • 1 Comment
Rockwell Poised For Post-Offering Bounce Ahead Of Phase III Results
Mike Havrilla • Fri, Mar 22 • 4 Comments
A Unique First-To-Market Investment Opportunity Look Into Sepsis, The 10th Most Common Cause Of Death
Edward Abraham • Tue, Mar 12 • 1 Comment
Amgen And The Biosimilar Threat: Lessons From Affymax
PropThink • Fri, Mar 8 • 3 Comments
Affymax: Dialysis Provider Pauses Omontys Pilot Expansion, Dead Money For Now
PropThink • Thu, Feb 14 • 6 Comments
Should Investors Buy The Defense Sector?
Monty Spivak • Mon, Jan 28 • 5 Comments
Affymax: Investor Darling In 2012 Now Has To Perform In 2013
Steve Daly • Mon, Jan 21 • 3 Comments
Comparing Dividend Payout Ratios Across Regions
David Hunkar • Wed, Dec 26, 2012 • 1 Comment
Affymax Poised To Snap Back
PropThink • Thu, Dec 20, 2012 • 5 Comments
Keryx Is Completely Misunderstood And May Double On Data
PropThink • Wed, Nov 21, 2012 • 1 Comment
World Demographics: Embracing The Gracious Aging World
Nick Chiu • Fri, Nov 16, 2012 • 15 Comments
Buy Rider Systems For Cheap Valuations, Dividends And Cost Cutting Measures
Qineqt • Wed, Oct 31, 2012
Berkshire Hathaway, Hedge Funds Are Buying DaVita
Qineqt • Tue, Oct 30, 2012 • 2 Comments
Ryder Systems: The Dividend Stock Is Cheap And Will Benefit From The Shale Gas Boom
Qineqt • Tue, Oct 9, 2012 • 2 Comments
Time To Follow Berkshire Into DaVita?
Tim Travis • Tue, Oct 2, 2012 • 10 Comments
Why European Stocks Look Attractive At Current Levels
David Hunkar • Sun, Sep 30, 2012 • 7 Comments
Rockwell Medical Overvalued Based On Significant Risk
Brian Marckx • Fri, Sep 14, 2012 • 8 Comments
Amgen And Its Biosimilar Competitors
Peter Geschek • Wed, Sep 5, 2012 • 4 Comments
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Tue, Sep 4, 2012 • 91 Comments

Fresenius Medical Care AG & Co. KGAA Management Discusses Q1 2013 Results - Earnings Call Transcript
Tue, Apr 30
Fresenius Medical Care AG & Co. KGAA Management Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Feb 26
Fresenius Medical Care AG & Co. KGAA Management Discusses Q3 2012 Results - Earnings Call Transcript
Wed, Oct 31, 2012
Fresenius Medical Care's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Wed, May 4, 2011
Fresenius Medical Care CEO Discusses Q4 2010 Results - Earnings Call Transcript
Wed, Feb 23, 2011
Fresenius Medical Care AG & Co.Q2 2010 Earnings Call Transcript
Thu, Aug 5, 2010
FRESENIUS MED ADS Q1 2010 Earnings Call Transcript
Tue, May 4, 2010
Fresenius Medical Care AG & Co. KGaA Q2 2009 Earnings Call Transcript
Tue, Aug 4, 2009
Fresenius Medical Care Q4 2008 Earnings Call Transcript
Mon, Mar 2, 2009
Fresenius Medical Care AG & Co. KgaA Q3 2007 Earnings Call Transcript
Thu, Nov 1, 2007

2012 biotech medal winners ... so far

at MarketWatch.com (Aug 1, 2012)
European Stocks to Watch: AXA strategist advises caution

at MarketWatch.com (Sep 28, 2010)
European Exporters Are Good Bet: Fund Managers

at CNBC.com (Jun 24, 2010)
As The Euro Crumbles, Who Loses & Who Wins?

at CNBC.com (May 14, 2010)
Europes Financial Woes A Good Thing?

at CNBC.com (May 13, 2010)

FMS vs. ETF Alternatives

Company Description

Currently, there's no company description for FMS.

Sector: Healthcare

Industry: Specialized Health Services

Country: Germany

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, March 14, 8:04 AM Fresenius Medical Care (FMS) receives a warning letter from the FDA saying that the design validation process for specific dialysis machines made in Utah is incomplete. However, the FDA doesn't require a product recall, and Fresenius doesn't expect the letter to affect its earnings guidance this year. (PR) Comment! [Healthcare]
Tuesday, February 26, 10:13 AM Fresenius Medical Care (FMS) declares annual dividend of €0.75/share, 9% increase from prior dividend of €0.69, subject to approval by shareholders. (PR) Comment! [Dividends]
Tuesday, February 26, 9:02 AM Fresenius Medical Care (FMS): Q4 net profit -17% to $257M; EBIT -4.7% to $559.1M; revenues +13% to $3.71B, North American sales +19% to $2.43B, revenue per treatment in U.S. clinics +4.8% to $368; international revenue +4% to $1.27B. Forecasts 2013 net profit of $1.1-1.2B, sales of above $14.6B, in line. Shares +2.8% in Frankfurt. (PR) Comment! [Healthcare, Earnings]
Monday, February 25, 7:28 AM Affymax (AFFY) prints at $3.41 premarket, -78.8%, following yesterday's report of the Omontys recall. AFFY has no other late-stage drugs in its pipeline. Piper expects shares to trade to cash value (~$2) "as investors take into account the lack of visibility." In play: AMGN, whose Epogen dominates the antianemia market (+2.4%), NKTR (which earns royalties on Omontys sales), and FMS, which pulled a trial two weeks ago (-1.3%). Comment! [Healthcare, On the Move]
Thursday, February 14, 9:58 AM Affymax (AFFY) collapses 28% after saying that Fresenius (FMS) is pausing the further expansion of a trial with Affymax's Omontys treatment for anemia in patients with kidney disease after injecting it in over 18,000 people. Fresenius will now study the results of the test for efficacy and safety. Fresenius said one in 1000 patients suffered allergic reactions, a small number of which were serious, although most were mild. Comment! [Healthcare, On the Move]
Monday, September 3, 2012, 4:22 AM Fresenius (FMS) drops a €3.1B bid for private-clinic operator Rhoen-Klinikum. Fresenius had planned to make a second offer at an unchanged price of €22.50/share, but the German health-care company's supervisory board wasn't overly keen on the deal, while a rival hospital operator filed an application to raise its stake in Rhoen-Klinikum to 10% in order to torpedo Fresenius. (PR) Comment! [Healthcare, M&A]
Thursday, July 12, 2012, 11:54 AM Affymax (AFFY +15.65%) after announcing that its partner, Takeda Pharmaceuticals, has signed an agreement to supply their anemia treatment Omontys to U.S. dialysis centers run by Germany's Fresenius Medical Care. Fresenius (FMS -2.1%) intends to initially use the drug in 100 centers before expanding the program. (PR) Comment! [Healthcare, On the Move]
Thursday, December 1, 2011, 12:00 PM Fresenius Medical (FMS +1.3%) gets a boost from a valuation upgrade by Morgan Stanley to Overweight from Equal Weight. Comment! [Healthcare, On the Move]
Tuesday, August 30, 2011, 9:00 AM Premarket gainers: LLNW +10%. AEZS +8%. PANL +6%. TGB +4%. DG +3%.
Losers: NBG -9%. CEDC -7%. LVLT -4%. ASBC -4%. FRO -3%. DB -3%. FMS -3%. GSK -3%. Comment! [On the Move]
Tuesday, August 2, 2011, 3:31 AM Fresenius Medical Care (FMS), the world's largest dialysis company, agrees to buy Liberty Dialysis Holdings for $1.7B including assumed debt, and American Access Care Holdings for $385M. The deals come as a new Medicare payment scheme pressures dialysis clinics to increase efficiency. (PR) Comment! [M&A, Healthcare]

Andrew Shapiro
http://seekingalpha.com/a/lh6r Sparton Q1 FY 2013 Call Highlights Temporary Nature Of Lower Profits $SPA $FMS $GR $NOC $NUVA $PH $RTN $SI
11/13/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
Check out my latest article - Sparton Corp Q1 FY 2013 Call Highlights Temporary Nature Of Lower Profits SPA FMS GR NOC NUVA PH RTN SI
11/13/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Markidesad
Trading halt for Focus Graphite FMS
10/29/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

The Wall Street Transcript
Pockets of Organic Growth in Health Care as Stability Trudges; Analyst Discusses $AMSG,$DGX, $LH, $DVA, $FMS, $UNH - http://su.pr/8jCFmR
8/16/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

arrow13
DVA...FMS...dialysis companies, I own four leases/buildings and they are expanding like crazy...big need...hospitals outsources to make room
3/15/12
Reply (1)

• !Report Abuse
View all 1 replies
arrow13: outsourcing to make room for more beds....good plays as more and more people need treatment..clean blood...
3/15/12
• !Report Abuse
Add a reply...

140 characters

Ryan Mallory
5 Stocks gaining momentum http://bit.ly/uhLbie FMS NWY INCY WIT JBLU
12/1/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dr. Kris
Today's *Blue Plate Specials* long portfolio pix: ARUN, BMA, FEIM, FMS, HS, JKS, NTCT, QUIK, SCOR, URRE.
9/21/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dr. Kris
Today's *Blue Plate Specials* portfolio pix: AIN, CLW, EFOI.OB, FMCN, FMS, HNT, PPCO, NCR, TGH, VOD
8/6/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

arrow13
DVA...FMS...dialysis companies, I own four leases/buildings and they are expanding like crazy...big need...hospitals outsources to make room
3/15/12
Reply (1)

• !Report Abuse
View all 1 replies
arrow13: outsourcing to make room for more beds....good plays as more and more people need treatment..clean blood...
3/15/12
• !Report Abuse
Add a reply...

140 characters

FMS Fresenius Medical Care AG & Co. KGAA

FMS

Fresenius Medical Care AG & Co. KGAA